“Long-Term Safety and Disease Control With Ruxolitinib Cream in Patients With More Severe Atopic Dermatitis: Pooled Results From Two Phase 3 Studies”. SKIN The Journal of Cutaneous Medicine 5, no. 6 (November 5, 2021): s66. Accessed May 18, 2025. https://skin.dermsquared.com/skin/article/view/1417.